G.H.J.M. Leyten

1.2k total citations
12 papers, 850 citations indexed

About

G.H.J.M. Leyten is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, G.H.J.M. Leyten has authored 12 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in G.H.J.M. Leyten's work include Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Molecular Biology Techniques and Applications (3 papers). G.H.J.M. Leyten is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Molecular Biology Techniques and Applications (3 papers). G.H.J.M. Leyten collaborates with scholars based in Netherlands, Curacao and Indonesia. G.H.J.M. Leyten's co-authors include Jack A. Schalken, Inge M. van Oort, Sander A. Jannink, Frank Smit, Theo M. de Reijke, Hans de Jong, Daphne Hessels, Ben C. Knipscheer, H. Vergunst and Erik B. Cornel and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

G.H.J.M. Leyten

12 papers receiving 841 citations

Peers

G.H.J.M. Leyten

PRM

SURGE

RHEUM

Hans de Jong Netherlands

Petrea Hodge United States

Martijn P.M.Q. van Gils Netherlands

Amina Ali United States

A. Partin United States

Chris Bangma Netherlands

Harri Visapää Finland

Alan W Partin United States

CHERYL M. YEMOTO United States

Andrew Erickson Finland

Hans de Jong Netherlands

G.H.J.M. Leyten

650 ×1.0

PRM

331 ×0.9

284 ×0.8

68 ×1.0

SURGE

72 ×1.2

RHEUM

Citations per year, relative to G.H.J.M. Leyten G.H.J.M. Leyten (= 1×) peers Hans de Jong

Countries citing papers authored by G.H.J.M. Leyten

Since Specialization

Citations

This map shows the geographic impact of G.H.J.M. Leyten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.H.J.M. Leyten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.H.J.M. Leyten more than expected).

Fields of papers citing papers by G.H.J.M. Leyten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.H.J.M. Leyten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.H.J.M. Leyten. The network helps show where G.H.J.M. Leyten may publish in the future.

Co-authorship network of co-authors of G.H.J.M. Leyten

This figure shows the co-authorship network connecting the top 25 collaborators of G.H.J.M. Leyten. A scholar is included among the top collaborators of G.H.J.M. Leyten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.H.J.M. Leyten. G.H.J.M. Leyten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Leyten, G.H.J.M., Inge M. van Oort, & Andries M. Bergman. (2019). Op metastasen gerichte behandeling van prostaatcarcinoom. 9(6-7). 108–116. 1 indexed citations

Neste, Leander Van, Rianne J. Hendriks, Siebren Dijkstra, et al.. (2016). Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score. European Urology. 70(5). 740–748. 257 indexed citations

Hendriks, Rianne J., Siebren Dijkstra, Erik B. Cornel, et al.. (2016). Elevated HOXC6/DLX1 mRNA biomarker levels in urine to help select patients at increased risk for high-grade prostate cancer detection upon prostate biopsy.. Journal of Clinical Oncology. 34(2_suppl). 31–31. 2 indexed citations

Leyten, G.H.J.M., Daphne Hessels, Frank Smit, et al.. (2015). Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer. Clinical Cancer Research. 21(13). 3061–3070. 164 indexed citations

Dijkstra, Siebren, G.H.J.M. Leyten, Sander A. Jannink, et al.. (2014). KLK3, PCA3, and TMPRSS2-ERG expression in the peripheral blood mononuclear cell fraction from castration-resistant prostate cancer patients and response to docetaxel treatment. The Prostate. 74(12). 1222–1230. 27 indexed citations

Leyten, G.H.J.M., Daphne Hessels, Sander A. Jannink, et al.. (2014). 351 QUATTRO, a four gene prognostic biomarker panel for prostate cancer. European Urology Supplements. 13(1). e351–e351. 1 indexed citations

Leyten, G.H.J.M., J.P. Michiel Sedelaar, Inge M. van Oort, et al.. (2013). Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI. International Journal of Molecular Sciences. 14(6). 11347–11355. 18 indexed citations

Dijkstra, Siebren, Frank Smit, G.H.J.M. Leyten, et al.. (2013). Prostate Cancer Biomarker Profiles in Urinary Sediments and Exosomes. The Journal of Urology. 191(4). 1132–1138. 92 indexed citations

Leyten, G.H.J.M., Daphne Hessels, Sander A. Jannink, et al.. (2012). Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer. European Urology. 65(3). 534–542. 268 indexed citations

10.

Leyten, G.H.J.M., Daphne Hessels, Erik B. Cornel, et al.. (2012). 2104 PROSPECTIVE MULTICENTER EVALUATION OF PCA3 AND TMPRSS2-ERG GENE FUSIONS AS DIAGNOSTIC AND PROGNOSTIC BIOMARKERS FOR PROSTATE CANCER. The Journal of Urology. 187(4S). 4 indexed citations

11.

Leyten, G.H.J.M., Daphne Hessels, Erik B. Cornel, et al.. (2012). 913 Prospective multicenter evaluation of PCA3+TMPRSS2-ERG as a diagnostic and prognostic marker panel for prostate cancer. European Urology Supplements. 11(1). e913–e913b. 7 indexed citations

12.

Dijkstra, Siebren, Agus Rizal Ardy Hariandy Hamid, G.H.J.M. Leyten, & Jack A. Schalken. (2012). Personalized Management in Low-Risk Prostate Cancer: The Role of Biomarkers. SHILAP Revista de lepidopterología. 2012. 1–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact